CYFRA 21-1 determination in patients with esophageal squamous cell carcinoma: Clinical utility for detection of recurrences

Hidetoshi Kawaguchi, Shinji Ohno, Mitsuhiro Miyazaki, Kenkichi Hashimoto, Akinori Egashira, Hiroshi Saeki, Masayuki Watanabe, Keizo Sugimachi

Research output: Contribution to journalArticle

58 Citations (Scopus)

Abstract

BACKGROUND. While there are reports that CYFRA 21-1 is a useful tumor marker, to our knowledge the clinical utility of this marker to detect recurrences for squamous cell carcinoma of the esophagus has not been addressed. METHODS. By immunoradiometric assay, human serum levels of CYFRA 21-1, SCC antigen and CEA were measured in esophageal squamous cell carcinoma patients prior to their initial treatment. Monthly follow-ups of these tumor markers was done after surgery. RESULTS. The diagnostic sensitivity of CYFRA 21-1 was 43.9% (18 of 41), a value superior to that for SCC antigen (26.8%) and CEA (17.0%) (P < 0.05). The positive rates of CYFRA 21-1 increased with progression of the disease, 22.2% of pTNM Stage 0-IIA and 77.8% of pTNM Stage IIB/III (P = 0.013), whereas SCC antigen and CEA rates were not related to pTNM stage. Among 13 patients with clinical evidence of a recurrence, 76.9% (10 of 13) exhibited an increase in CYFRA 21-1, and this increase was evident before clinical detection of the recurrence in 9 of these 13 patients (69.2%). Consequently, postoperative elevations of serum CYFRA 21-1 levels were indicative of a tumor recurrence 1-13 months before acquisition of clinical and radiological data. CONCLUSIONS. The assay of CYFRA 21-1 is useful not only for diagnosis but also for close monitoring of patients with esophageal squamous cell carcinoma. (C) 2000 American Cancer Society.

Original languageEnglish
Pages (from-to)1413-1417
Number of pages5
JournalCancer
Volume89
Issue number7
DOIs
Publication statusPublished - Oct 1 2000

All Science Journal Classification (ASJC) codes

  • Oncology
  • Cancer Research

Fingerprint Dive into the research topics of 'CYFRA 21-1 determination in patients with esophageal squamous cell carcinoma: Clinical utility for detection of recurrences'. Together they form a unique fingerprint.

  • Cite this

    Kawaguchi, H., Ohno, S., Miyazaki, M., Hashimoto, K., Egashira, A., Saeki, H., Watanabe, M., & Sugimachi, K. (2000). CYFRA 21-1 determination in patients with esophageal squamous cell carcinoma: Clinical utility for detection of recurrences. Cancer, 89(7), 1413-1417. https://doi.org/10.1002/1097-0142(20001001)89:7<1413::AID-CNCR1>3.0.CO;2-I